<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:georss="http://www.georss.org/georss">
  <channel>
    <image>
      <title>ReleaseWire</title>
      <url>http://media.releasewire.com/photos/show/?id=68004&amp;size=small</url>
      <link>http://www.releasewire.com/</link>
    </image>
    <title>ReportsandReports - Latest Press Releases on ReleaseWire</title>
    <link>http://www.releasewire.com/company/reportsandreports-16368.htm</link>
    <description/>
    <language>en-us</language>
    <link xmlns="http://www.w3.org/2005/Atom" href="http://sbwire.superfeedr.com/" rel="hub"/>
    <link xmlns="http://www.w3.org/2005/Atom" href="http://feeds.releasewire.com/rss/full/company/16368" rel="self"/>
    <item>
      <title>ReportsandReports- Aleppo Pharmaceutical Industries, L.L.C.-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">Aleppo Pharmaceutical Industries, L.L.C.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.</p><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/14/2010 --   Aleppo Pharmaceutical Industries, L.L.C.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports:<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
Keep track of your competitors and partners by better understanding their product pipeline.<br />
Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
Product Summary<br />
Product Details<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58385">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58385&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Thu, 14 Oct 2010 08:53:41 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- Alborz Darou Co.-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">
</p><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/14/2010 --   Alborz Darou Co.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports:<br />
<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
<br />
Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
<br />
Keep track of your competitors and partners by better understanding their product pipeline.<br />
<br />
Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
<br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
Product Summary<br />
Product Details<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a><br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a><br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58365">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58365&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Thu, 14 Oct 2010 08:30:00 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- Albert Einstein College of Medicine of Yeshiva University-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/13/2010 --   Albert Einstein College of Medicine of Yeshiva University-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information, deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
 Product Summary<br />
Product Details<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58359">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58359&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Wed, 13 Oct 2010 09:00:00 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- Albert David Limited-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/12/2010 --   Albert David Limited-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
Product Summary<br />
Product Details<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58337">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58337&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Tue, 12 Oct 2010 09:21:03 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- Akrimax Pharmaceuticals, LLC-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/09/2010 --   Akrimax Pharmaceuticals, LLC-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
Keep track of your competitors and partners by better understanding their product pipeline.<br />
Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
 <br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
 <br />
Product Summary<br />
Product Details<br />
Recent Updates<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58301">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58301&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Sat, 09 Oct 2010 11:59:07 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title> Report on Ain Medicare Sdn. Bhd.-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p>Dallas, Taxas -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/09/2010 --   Ahn-Gook Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
<br />
Business Summary<br />
Financials<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
 <br />
Product Summary<br />
Product Details<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
<br />
Browse the complete Report on Ain Medicare Sdn. Bhd.-Detailed Product Pipeline<br />
<br />
Browse All Life Science Analytics Research Reports at Life Science Analytics<br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58256">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58256&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Sat, 09 Oct 2010 09:52:12 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- - Ahn-Gook Pharmaceutical Co., Ltd.-Detailed Product Pipelinettt</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">Ahn-Gook Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.</p><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/08/2010 --   Ahn-Gook Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
<br />
Business Summary<br />
Financials<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
 <br />
Product Summary<br />
Product Details<br />
<br />
About Us:<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/58246">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=58246&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Fri, 08 Oct 2010 07:44:42 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- AFFiRiS GmbH-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">AFFiRiS GmbH-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.</p><p>Dallas, Taxas -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/06/2010 --   AFFiRiS GmbH-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
 <br />
Table Of Contents<br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
Product Summary<br />
Product Details<br />
<br />
About ReportsandReports<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
<br />
Browse the complete Report on AFFiRiS GmbH-Detailed Product Pipeline<br />
<br />
Browse All Life Science Analytics Research Reports at Life Science Analytics<br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/57970">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=57970&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Wed, 06 Oct 2010 16:32:09 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- Advance Pharmaceutical Co., Ltd.-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">Advance Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.</p><p>Dallas, Taxas -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 10/05/2010 --   Advance Pharmaceutical Co., Ltd.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
<br />
Table Of Contents<br />
 <br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
 <br />
Product Summary<br />
Product Details<br />
<br />
About Us:<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/57917">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=57917&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Tue, 05 Oct 2010 10:11:05 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>ReportsandReports- Advanced in Vitro Cell Technologies, s.l. (Advancell)-Detailed Product Pipeline</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">Advanced in vitro cell technologies, s.l. (Advancell)-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.</p><p>Dallas, Taxas -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 09/27/2010 --   Advanced in vitro cell technologies, s.l. (Advancell)-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.<br />
<br />
Scope of the reports<br />
<br />
Each Life Science Analytics&apos; Pipeline Report provides the user with real detail on a company&apos;s pipeline.<br />
<br />
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company&apos;s product pipeline and disease hub classification.<br />
<br />
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company&apos;s deals and alliances and recent corporate news including key milestones.<br />
<br />
Key benefits<br />
• Understand a company&apos;s strategic position by accessing detailed independent intelligence on its product pipeline.<br />
• Keep track of your competitors and partners by better understanding their product pipeline.<br />
• Monitor a company&apos;s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.<br />
Table Of Contents<br />
 <br />
Business Summary<br />
Product Glance<br />
Products by Phase of Development<br />
Products by Disease Hub Classification<br />
Products by Indication<br />
 <br />
Product Summary<br />
Product Details<br />
<br />
About Us:<br />
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact:<br />
Ms. Sunita<br />
7557 Rambler road,<br />
Suite 727, Dallas, TX 75231<br />
Tel: +1-888-989-8004<br />
<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.proarticles.co.uk/" href="http://reportsandreports.proarticles.co.uk/">http://reportsandreports.proarticles.co.uk/</a> <br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>Nilesh Kindarle<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/57920">Click to Email Nilesh Kindarle</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=57920&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Mon, 27 Sep 2010 08:00:00 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>Forties, United Kingdom, Commercial Asset Valuation and Forecast to 2025 Now Available on ReportsandReports</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">The giant Forties field is situated on UK Block 21/10, which is in the northern part of the British sector of the North Sea. It lies at water depth of 106m and is 180 km from Aberdeen city.</p><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 09/07/2010 --   ReportsandReports announce it will carry Forties, United Kingdom, Commercial Asset Valuation and Forecast to 2025 Market Research Report in its Store.<br />
<br />
Browse complete Report on: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/forties-united-kingdom-commercial-asset-valuation-and-forecast-/" href="http://www.reportsandreports.com/market-reports/forties-united-kingdom-commercial-asset-valuation-and-forecast-/">http://www.reportsandreports.com/market-reports/forties-united-kingdom-commercial-asset-valuation-and-forecast-/</a><br />
<br />
The giant Forties field is situated on UK Block 21/10, which is in the northern part of the British sector of the North Sea. It lies at water depth of 106m and is 180 km from Aberdeen city. It was discovered in 1970. Forties was just the second oil field to be discovered in the UK North Sea.<br />
<br />
Forties oil field is jointly owned by Apache North Sea Limited, Esso Exploration &amp; Production UK Limited and Shell UK Limited. Apache North Sea Limited is the operator of the field with 97.14% interest. The field was initially owned by BP. But in 2003, it was acquired by Apache North Sea Limited at a price of $683 million. For Apache it costed $1.3 billion after including the Malaysian Government&apos;s take.<br />
<br />
Forties produces single product crude oil. It is a high quality product with API of 37 ° and is sweet due to low sulfur content. Apache North Sea Limited estimated the recoverable reserves of the field to be 2.82 billion barrels.<br />
<br />
It has produced 2.63 billion barrels of crude oil till 2009, with around 23 million barrels being produced in the year 2009. Because of the redevelopment plans of Apache North Sea Limited the field is estimated to produce till 2025.<br />
<br />
The peak production was around 184 million barrels in 1979, when the field supplied 25% of the UK&apos;s oil demand.<br />
<br />
Scope<br />
• The report provides detailed information on oil and gas production, infrastructure, reserves, geology, operator and equity partners and the latest fiscal terms applicable to the asset and provides its fair value (Remaining Net Present Value) based on remaining reserves, forecast production, capital and operational costs, fiscal regime and commodity prices.<br />
<br />
• The report also provides additional valuation parameters like Internal Rate of Return (IRR), Profitability Index (PI), Pay Back (discounted and undiscounted), Entitlement Production (EP) and Working Interest (WI) to enhance your decision making process.<br />
<br />
• This report provides detailed sensitivity analysis of the remaining NPV with changes in the commodity prices, discount rate, production and key fiscal terms.<br />
<br />
• Detailed cash flows over the life of the asset are included in the report. These cash flows cover a wide range of calculations related to various payments to the government/licensing authority.<br />
<br />
• Interactive Excel models can be used to derive custom valuations, sensitivities and cash flows based on the specific inputs by the user in the model. These custom inputs vary from production data, cost information, price information and fiscal terms information.<br />
<br />
Reasons to buy<br />
<br />
• Make well informed investment decisions based on detailed operational analysis and cash flow forecasts<br />
• Estimate the fair value of your future investment under different economic and fiscal conditions<br />
• Value a prospective investment target through a comprehensive analysis using focused forecasting and valuation methodologies.<br />
• Supporting interactive excel model will enhance your decision making capability in a more rapid and time sensitive manner<br />
• Evaluate how the changes in the country&apos;s fiscal policies impact the cash flows and the present value of the asset<br />
<br />
Table of Contents <br />
<br />
1.1 List of Tables 3<br />
1.2 List of Figures 3<br />
<br />
2 Forties, United Kingdom, Introduction 4<br />
<br />
3 Forties, United Kingdom, Geology and Formations 6<br />
<br />
4 Forties, United Kingdom, Equity Partners 8<br />
<br />
5 Forties, United Kingdom, Crude Oil Reserves 9<br />
<br />
6 Forties, United Kingdom, Key Fiscal Terms 9<br />
6.1 Royalty 9<br />
6.2 Bonuses 9<br />
6.3 Rentals 9<br />
6.4 Fees 9<br />
6.5 Taxation 9<br />
6.6 Petroleum Revenue Tax (PRT) 9<br />
6.7 Deductions 10<br />
6.8 Capital Allowance 10<br />
6.9 Withholding Tax 11<br />
6.10 Ring Fence 11<br />
<br />
7 Forties, United Kingdom, Infrastructure 12<br />
7.1 Upstream Infrastructure 12<br />
7.2 Midstream Infrastructure 12<br />
<br />
8 Forties, United Kingdom, Development Plan 13<br />
<br />
9 Forties, United Kingdom, Crude Oil Production 14<br />
<br />
10 Forties, United Kingdom, Field Economics 17<br />
10.1 Forties, Economic Assumptions 17<br />
10.1.1 Forecast Commodity Prices 17<br />
10.1.2 Inflation 17<br />
10.1.3 Discount Rate and Representation of Cash Flows 17<br />
10.1.4 Sensitivity 17<br />
10.1.5 Access to the Economic Model 17<br />
10.2 Forties, United Kingdom, Cash Flow Analysis 18<br />
10.3 Forties, United Kingdom, Remaining PV Sensitivity Analysis 19<br />
10.3.1 Remaining NPV Sensitivity to Discount Rates 19<br />
10.3.2 Remaining NPV Sensitivity to Change in Commodity Prices and Production 20<br />
10.3.3 Remaining NPV Sensitivity to Petroleum Revenue Tax and Production Rate 21<br />
<br />
11 Forties, United Kingdom, Summary Cash Flows 22<br />
11.1 Forties, United Kingdom, Front End Load Due To Fiscal Policy 23<br />
11.2 Forties, United Kingdom, Tax Liability 24<br />
<br />
12 Appendix 25<br />
12.1 Methodology 25<br />
12.2 Coverage 25<br />
12.3 Secondary Research 25<br />
12.4 Primary Research 25<br />
12.5 E&amp;P Forecasts 26<br />
12.6 Capital Costs 26<br />
12.7 Exploration and Appraisal (E&amp;A) Costs 26<br />
12.8 Operating Costs 26<br />
12.9 Expert Panel Validation 27<br />
12.10 About GlobalData<br />
12.11 Contact Us<br />
12.12 Disclaimer<br />
<br />
1.1 List of Tables<br />
<br />
Table 1: Forties, United Kingdom, Key Asset Data, 2010 5<br />
Table 2: Forties, United Kingdom, Field Reserves, January 2010 10<br />
Table 3: Forties, United Kingdom, Crude Oil Historic and Forecast Production, Thousand Barrels, 1975-2025 16<br />
Table 4: Forties, United Kingdom, Commodity Price Assumptions, 2010-2025 18<br />
Table 5: Forties, United Kingdom, Project Analysis Metrics, 2010 19<br />
Table 6: Forties, United Kingdom, Remaining PV Sensitivity Analysis Over Discount Rate Vs. Commodity Price Change, in Million Dollars 20<br />
Table 7: Forties, United Kingdom, Remaining PV Sensitivity Analysis over Commodity Price Change Vs Production Rate, in Million Dollars 21<br />
Table 8: Forties, United Kingdom, Remaining PV Sensitivity Analysis at 10% Discount Rate over Petroleum Revenue Tax Change Vs Production Rate, in Million Dollars 22<br />
Table 9: Forties, United Kingdom, Asset Summary Cash Flows, Thousand USD, 1971-2025 23<br />
Table 10: Forties, United Kingdom, Front End Load, Thousand USD, 1971-2025 24<br />
Table 11: Forties, United Kingdom, Tax Liability Estimations, Thousands USD, 1971-2025 25<br />
<br />
1.2 List of Figures<br />
<br />
Figure 1: Forties, United Kingdom, Location Map 6<br />
Figure 2: Forties, United Kingdom, Geology Formations 8<br />
Figure 3: Forties, United Kingdom, Current Equity Details, 2010 9<br />
Figure 4: Forties, United Kingdom, Infrastructure Block Diagram 13<br />
Figure 5: Forties, United Kingdom, Crude Oil Historic Production and Forecast, 1975-2025 15<br />
Figure 6: Forties, United Kingdom,  Gross Revenue Versus Tax Cash Flow Analysis, 1975-2025 19<br />
Figure 7: Forties, United Kingdom, Remaining PV Sensitivity Analysis Over Discount Rate Vs. Commodity Price Change, in Million Dollars 20<br />
Figure 8: Forties, United Kingdom, Remaining PV Sensitivity Analysis over Change in Production Vs. Commodity Price Change, in Million Dollars 21<br />
Figure 9: Forties, United Kingdom, Remaining PV Sensitivity Analysis Over Income Tax Change Vs. Production Rate, in Million Dollars 22<br />
<br />
Browse complete Report on: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/forties-united-kingdom-commercial-asset-valuation-and-forecast-/" href="http://www.reportsandreports.com/market-reports/forties-united-kingdom-commercial-asset-valuation-and-forecast-/">http://www.reportsandreports.com/market-reports/forties-united-kingdom-commercial-asset-valuation-and-forecast-/</a><br />
<br />
Browse all Energy and Power Market Research Reports on:<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-research/energy-and-power-supplies/" href="http://www.reportsandreports.com/market-research/energy-and-power-supplies/">http://www.reportsandreports.com/market-research/energy-and-power-supplies/</a><br />
<br />
Browse all GlobalData Market Research Reports on:<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/Publishers/globaldata/" href="http://www.reportsandreports.com/Publishers/globaldata/">http://www.reportsandreports.com/Publishers/globaldata/</a><br />
<br />
Browse all Latest Report on:<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/LatestReport.aspx" href="http://www.reportsandreports.com/LatestReport.aspx">http://www.reportsandreports.com/LatestReport.aspx</a><br />
<br />
Related Reports:<br />
<br />
Andrew Unit, United Kingdom, Commercial Asset Valuation and Forecast to 2025<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/andrew-unit-united-kingdom-commercial-asset-valuation-and-forec/" href="http://www.reportsandreports.com/market-reports/andrew-unit-united-kingdom-commercial-asset-valuation-and-forec/">http://www.reportsandreports.com/market-reports/andrew-unit-united-kingdom-commercial-asset-valuation-and-forec/</a><br />
<br />
Bonga Field, Nigeria, Commercial Asset Valuation and Forecast to 2025<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/bonga-field-nigeria-commercial-asset-valuation-and-forecast-to-/" href="http://www.reportsandreports.com/market-reports/bonga-field-nigeria-commercial-asset-valuation-and-forecast-to-/">http://www.reportsandreports.com/market-reports/bonga-field-nigeria-commercial-asset-valuation-and-forecast-to-/</a><br />
<br />
Edop, Nigeria, Commercial Asset Valuation and Forecast to 2025<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/" href="http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/">http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/</a><br />
<br />
About Reports and Reports<br />
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact: <br />
Ms. Sunita<br />
7557 Rambler road,Suite 727, <br />
Dallas, <br />
TX 75231 <br />
Tel: +1-888-989-8004<br />
Website: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br />
Blog: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
Blog: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>ReportsandReports<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/55837">Click to Email ReportsandReports</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=55837&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Tue, 07 Sep 2010 08:50:52 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
    <item>
      <title>Edop, Nigeria, Commercial Asset Valuation and Forecast to 2025 Now Available on ReportsandReports</title>
      <link>http://www.releasewire.com/press-releases/release-3.htm</link>
      <description><![CDATA[<div class="newsleft"><div class="newsbody"><p class="subheadline">Edop is an offshore field in the deep waters of Niger Delta in Gulf of Guinea region. The field is located at a depth of 9,215 feet/2,808m.</p><p>Dallas, TX -- (<a rel="nofollow" href="http://www.sbwire.com/">SBWIRE</a>) -- 09/07/2010 --   ReportsandReports announce it will carry Edop, Nigeria, Commercial Asset Valuation and Forecast to 2025 now available on ReportsandReports Market Research Report in its Store.<br />
<br />
Browse complete Report on: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/" href="http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/">http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/</a><br />
<br />
Edop is an offshore field in the deep waters of Niger Delta in Gulf of Guinea region. The field is located at a depth of 9,215 feet/2,808m. The field was discovered in the year 1981 by Exxon Mobil Corporation.Mobil Corporation, a subsidiary of Exxon Mobil Corporation in Nigeria has been the operator of Edop since 1981. As per the Nigerian fiscal regime, the operator entered into a joint venture with Nigerian National Petroleum Corporation. Hence the stake of Mobil Corporation is 40% and that of NNPC is 60%.<br />
<br />
The field reservoir contains sweet (low sulphur about 0.1%) crude oil with an average specific gravity of around 37.4° API (American Petroleum Institute). Edop produced 12.4 million barrels of crude oil during 2009. The cumulative production to 2009 is 585.3 million barrels of oil. Peak production from the field was 60.2 million barrels of oil in 1995.The field life of Edop is expected to be 39 years, with production ending in 2025. The field is expected to generate $13 billion in revenues (undiscounted) during its remaining life (starting from January 1, 2010) and is expected to yield an IRR of around 22.91%.<br />
<br />
Scope<br />
• The report provides detailed information on oil and gas production, infrastructure, reserves, geology, operator and equity partners and the latest fiscal terms applicable to the asset and provides its fair value (Remaining Net Present Value) based on remaining reserves, forecast production, capital and operational costs, fiscal regime and commodity prices.<br />
<br />
• The report also provides additional valuation parameters like Internal Rate of Return (IRR), Profitability Index (PI), Pay Back (discounted and undiscounted), Entitlement Production (EP) and Working Interest (WI) to enhance your decision making process.<br />
<br />
• This report provides detailed sensitivity analysis of the remaining NPV with changes in the commodity prices, discount rate, production and key fiscal terms.<br />
<br />
• Detailed cash flows over the life of the asset are included in the report. These cash flows cover a wide range of calculations related to various payments to the government/licensing authority.<br />
<br />
• Interactive Excel models can be used to derive custom valuations, sensitivities and cash flows based on the specific inputs by the user in the model. These custom inputs vary from production data, cost information, price information and fiscal terms information.<br />
<br />
Reasons to buy<br />
• Make well informed investment decisions based on detailed operational analysis and cash flow forecasts<br />
• Estimate the fair value of your future investment under different economic and fiscal conditions<br />
• Value a prospective investment target through a comprehensive analysis using focused forecasting and valuation methodologies.<br />
• Supporting interactive excel model will enhance your decision making capability in a more rapid and time sensitive manner<br />
• Evaluate how the changes in the country&apos;s fiscal policies impact the cash flows and the present value of the asset.<br />
<br />
Table of contents<br />
1.1 List of Tables 4<br />
1.2 List of Figures 4<br />
<br />
2 Executive Summary 5<br />
<br />
3 Edop, Nigeria, Introduction 7<br />
<br />
4 Edop, Nigeria, Geology and Formation 9<br />
<br />
5 Edop, Nigeria, Equity Partners 10<br />
<br />
6 Edop, Nigeria, Crude Oil and Gas Reserves 10<br />
<br />
7 Edop, Nigeria, Key Fiscal Terms 11<br />
7.1 Contract Type 11<br />
7.2 Royalty 11<br />
7.3 Fees 12<br />
7.4 Petroleum Profit Tax 12<br />
7.5 Deductions and Depreciation 12<br />
7.6 Petroleum Investment Allowance 12<br />
7.7 Withholding Tax 13<br />
7.8 Ring Fence 13<br />
<br />
8 Edop, Nigeria, Infrastructure, Development Plan, Investment and Expenditure 14<br />
<br />
9 Edop, Nigeria, Crude Oil Production 15<br />
<br />
10 Edop, Nigeria, Economics 17<br />
10.1 Edop, Economic Assumptions 17<br />
10.1.1 Forecast Commodity Prices 17<br />
10.1.2 Inflation 17<br />
10.1.3 Discount Rate and Representation of Cash Flows 17<br />
10.1.4 Sensitivity 17<br />
10.1.5 Access to the Economic Model 17<br />
<br />
11 Edop, Nigeria, Cash Flow Analysis 18<br />
11.1 Edop, Nigeria, Remaining PV Sensitivity Analysis 20<br />
11.1.1 Remaining NPV Sensitivity to Discount Rates 20<br />
11.1.2 Remaining NPV Sensitivity to Change in Commodity Prices and Production 21<br />
11.1.3 Remaining NPV Sensitivity to Income Tax and Production Rate 22<br />
11.2 Edop, Nigeria, Summary Cash Flows 23<br />
11.3 Edop, Nigeria, Front End Load Estimations 25<br />
11.4 Edop, Nigeria, Tax Liability 26<br />
<br />
12 Appendix 28<br />
12.1 Methodology 28<br />
12.2 Coverage 28<br />
12.3 Secondary Research 28<br />
12.4 Primary Research 29<br />
12.5 E&amp;P Forecasts 29<br />
12.6 Capital Costs 30<br />
12.7 Exploration and Appraisal (E&amp;A) Costs 30<br />
12.8 Operating Costs 30<br />
12.9 Expert Panel Validation 30<br />
12.10 About GlobalData<br />
12.11 Contact Us<br />
12.12 Disclaimer<br />
<br />
1.1 List of Tables<br />
<br />
Table 1: Edop, Nigeria, Key Valuation Metrics, 2010 7<br />
Table 2: Edop, Nigeria, Key Equity Partners,2010 7<br />
Table 3: Edop, Nigeria, Key Asset Data, 2010 8<br />
Table 4: Edop, Nigeria, Crude Oil Reserves, 2010 11<br />
Table 5: Nigeria, Crude Oil and Natural Gas, Offshore Royalty Rate for Joint Venture Contracts, 2009 12<br />
Table 6: Nigeria, Crude Oil and Natural Gas, Petroleum Investment Allowances, 2009 13<br />
Table 7: Edop, Nigeria, Crude oil, Historic and Forecast Production, 1987-2025 17<br />
Table 8: Edop, Nigeria, Commodity Price Assumptions, 1997-2020 18<br />
Table 9: Edop, Nigeria, Project Analysis Metrics, 2010 19<br />
Table 10: Edop, Nigeria, Remaining PV Sensitivity Analysis Over Discount Rate  Change Vs. Commodity Price Change, in $m,2010 21<br />
Table 11: Edop, Nigeria,  Remaining PV Sensitivity Analysis Over Commodity Price  Change Vs. Production Change, $m, 2010 22<br />
Table 12: Edop, Nigeria Remaining PV Sensitivity Analysis at 10% Discount Rate over Income Tax Change Vs Production Rate, in, $m 2010 23<br />
Table 13: Edop, Nigeria, Asset Summary Cash Flows, Thousand $, 1985-2025 24<br />
Table 14: Edop, Nigeria, Front End Load, Thousand $, 1987-2025 26<br />
Table 15: Edop, Nigeria, Tax Liability Estimations, Thousand $, 1990-2025 27<br />
<br />
1.2 List of Figures<br />
<br />
Figure 1: Edop, Nigeria, Historic and Forecast Production, 2010 6<br />
Figure 2: Edop, Nigeria, Gross Revenue Split, %, 2010 6<br />
Figure 3: Edop, Nigeria, NPV Sensitivity, 2010 7<br />
Figure 4: Edop, Nigeria, Location, 2010 9<br />
Figure 5: Edop, Nigeria, Cross section of Reservoir,2010 10<br />
Figure 6: Edop, Nigeria, Current Equity Details, 2010 11<br />
Figure 7: Edop, Nigeria, Historic Production and Forecast, Oil Production, Thousand Barrels, 1987-2025 16<br />
Figure 8: Edop, Nigeria, Gross Revenue versus Post Tax Cash Flows, $m,1995-2020 19<br />
Figure 9: Edop, Nigeria, Remaining PV Sensitivity Analysis Over Discount Rate Vs. Commodity Price Change, in $m, 2010 21<br />
Figure 10: Edop, Nigeria, Remaining PV Sensitivity Analysis Over  Commodity Price  Change Vs. Production Change,2010 22<br />
Figure 11: Edop, Nigeria, Remaining PV Sensitivity Analysis Over Income Tax Change Vs. Production  Rate, in $m, 2010 23<br />
<br />
<br />
Browse complete Report on: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/" href="http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/">http://www.reportsandreports.com/market-reports/edop-nigeria-commercial-asset-valuation-and-forecast-to-2025/</a><br />
<br />
Browse all Energy and Power Market Research Reports on:<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-research/energy-and-power-supplies/" href="http://www.reportsandreports.com/market-research/energy-and-power-supplies/">http://www.reportsandreports.com/market-research/energy-and-power-supplies/</a><br />
<br />
Browse all GlobalData Market Research Reports on:<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/Publishers/globaldata/" href="http://www.reportsandreports.com/Publishers/globaldata/">http://www.reportsandreports.com/Publishers/globaldata/</a><br />
<br />
Browse all Latest Report on:<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/LatestReport.aspx" href="http://www.reportsandreports.com/LatestReport.aspx">http://www.reportsandreports.com/LatestReport.aspx</a><br />
<br />
Related Reports:<br />
<br />
Bonga Field, Nigeria, Commercial Asset Valuation and Forecast to 2025<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/bonga-field-nigeria-commercial-asset-valuation-and-forecast-to-/" href="http://www.reportsandreports.com/market-reports/bonga-field-nigeria-commercial-asset-valuation-and-forecast-to-/">http://www.reportsandreports.com/market-reports/bonga-field-nigeria-commercial-asset-valuation-and-forecast-to-/</a><br />
<br />
Syncrude, Canada, Commercial Asset Valuation and Forecast to 2057<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/syncrude-canada-commercial-asset-valuation-and-forecast-to-2057/" href="http://www.reportsandreports.com/market-reports/syncrude-canada-commercial-asset-valuation-and-forecast-to-2057/">http://www.reportsandreports.com/market-reports/syncrude-canada-commercial-asset-valuation-and-forecast-to-2057/</a><br />
<br />
Alve, Norway, Commercial Asset Valuation and Forecast to 2021<br />
<a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/market-reports/alve-norway-commercial-asset-valuation-and-forecast-to-2021/" href="http://www.reportsandreports.com/market-reports/alve-norway-commercial-asset-valuation-and-forecast-to-2021/">http://www.reportsandreports.com/market-reports/alve-norway-commercial-asset-valuation-and-forecast-to-2021/</a><br />
<br />
About Reports and Reports<br />
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.<br />
<br />
Contact: <br />
Ms. Sunita<br />
7557 Rambler road,Suite 727, <br />
Dallas, <br />
TX 75231 <br />
Tel: +1-888-989-8004<br />
Website: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://www.reportsandreports.com/" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br />
Blog: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsnreports.wordpress.com/" href="http://reportsnreports.wordpress.com/">http://reportsnreports.wordpress.com/</a><br />
Blog: <a class="extlink"  rel="nofollow noopener"  target="_blank"  title="http://reportsandreports.blogspot.com/" href="http://reportsandreports.blogspot.com/">http://reportsandreports.blogspot.com/</a><br />
</p><p>For more information on this press release visit: <a rel="nofollow" href="http://www.releasewire.com/press-releases/release-3.htm">http://www.releasewire.com/press-releases/release-3.htm</a></p></div><h2>Media Relations Contact</h2><p>ReportsandReports<br />ReportsandReports<br />Telephone: 888-989-8004<br />Email: <a rel="nofollow" href="http://www.sbwire.com/press-releases/contact/55836">Click to Email ReportsandReports</a><br />Web: <a rel="nofollow" href="http://www.reportsandreports.com/">http://www.reportsandreports.com/</a><br /></div><div><p><img src="https://cts.releasewire.com/v/?sid=55836&amp;s=f&amp;v=f" width="1" height="1" alt=""><span></span></p></div>]]></description>
      <pubDate>Tue, 07 Sep 2010 08:49:25 -0500</pubDate>
      <guid>http://www.releasewire.com/press-releases/release-3.htm</guid>
    </item>
  </channel>
</rss>
